Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Centers for Medicare and Medicaid Services (“CMS”) Level II Healthcare Common Procedure Coding System (“HCPCS”) code dedicated to the Company’s AC5® Advanced Wound System (“AC5”) went into effect on April 1, 2023.
Related news for (ARTH)
- Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
- Arch Therapeutics Provides Year End Operational Update
- Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
- Arch Therapeutics Provides AC5® Commercialization Update
- Arch Therapeutics Completes Financing as Bridge to Uplisting